V
Verena Niederberger
Researcher at Medical University of Vienna
Publications - 60
Citations - 2790
Verena Niederberger is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Immunoglobulin E & Allergen. The author has an hindex of 30, co-authored 60 publications receiving 2396 citations.
Papers
More filters
Journal ArticleDOI
EAACI Molecular Allergology User's Guide.
Paolo Maria Matricardi,Jörg Kleine-Tebbe,Hans Jürgen Hoffmann,Rudolf Valenta,Christiane Hilger,Stephanie Hofmaier,Rob C. Aalberse,Ioana Agache,Riccardo Asero,Barbara Ballmer-Weber,Domingo Barber,Kirsten Beyer,Tilo Biedermann,M. B. Bilò,Simon Blank,Barbara Bohle,Philipp P. Bosshard,Heimo Breiteneder,Helen A. Brough,Luis Caraballo,J-C Caubet,Reto Crameri,Janet M. Davies,Nikolaos Douladiris,M. Ebisawa,Philippe Eigenmann,Montserrat Fernandez-Rivas,Fatima Ferreira,Gabriele Gadermaier,Martin Glatz,Robert G. Hamilton,Thomas Hawranek,P W Hellings,Karin Hoffmann-Sommergruber,Thilo Jakob,Uta Jappe,Marek Jutel,Sandip D. Kamath,Edward F. Knol,Peter Korošec,Annette Kuehn,Gideon Lack,Gideon Lack,Andreas L. Lopata,Mika J. Mäkelä,Martine Morisset,Verena Niederberger,Anna Nowak-Wegrzyn,Nikolaos G. Papadopoulos,Elide A. Pastorello,Gabrielle Pauli,Thomas A.E. Platts-Mills,Daniela Posa,Lars K. Poulsen,Monika Raulf,Joaquín Sastre,Enrico Scala,Johannes Schmid,Peter Schmid-Grendelmeier,M. van Hage,R. van Ree,Stefan Vieths,Richard W. Weber,Magnus Wickman,Antonella Muraro,Markus Ollert +65 more
TL;DR: The European Academy of Allergy and Clinical Immunology (EAACI) Molecular Allergology User's Guide (MAUG) as mentioned in this paper provides comprehensive information on important allergens and describes the diagnostic options using component-resolved diagnosis (CRD).
Journal ArticleDOI
Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives
Ashok Purohit,Verena Niederberger,M. Kronqvist,Friedrich Horak,R. Grönneberg,Roland Suck,B. Weber,H. Fiebig,M. van Hage,Gabrielle Pauli,Rudolf Valenta,Oliver Cromwell +11 more
TL;DR: This poster focuses on Birch pollen from related trees of the Fagales order, which is a major cause of allergic rhinitis, conjunctivitis, and asthma through the spring season in northern and central Europe.
Journal ArticleDOI
Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future
TL;DR: The characteristics of recombinant and synthetic allergy vaccines that have reached clinical evaluation are reviewed and how molecular vaccine approaches can make AIT more safe and effective and thus more convenient are discussed.
Journal ArticleDOI
Recombinant allergens for allergen-specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergens
TL;DR: Recombinant allergens for allergen‐specific immunotherapy: 10 years anniversary of immunotherapy with recombinant allergen.
Journal ArticleDOI
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
Margarete Focke-Tejkl,Milena Weber,Katarzyna Niespodziana,Angela Neubauer,Hans Huber,Rainer Henning,Gottfried Stegfellner,Bernhard Maderegger,Martina Hauer,Frank Stolz,Verena Niederberger,Katharina Marth,Julia Eckl-Dorna,Richard Weiss,Josef Thalhamer,Katharina Blatt,Peter Valent,Rudolf Valenta +17 more
TL;DR: A recombinant hypoallergenic grass pollen allergy vaccine (BM32) consisting of 4 recombinant PreS-fused grass pollen allergen peptides was developed for safe immunotherapy of grass pollen allergies.